Please login to the form below

Not currently logged in
Email:
Password:

Albumedix appoints Dr Giles Campion as CMO

He brings experience from Novartis and BioMarin

Albumedix Dr Giles CampionCopenhagen, Denmark-based Albumedix has appointed Dr Giles Campion as its chief medical officer and member of the executive team.

Dr Campion will be responsible for the firm's global development efforts, with a particular focus on its albumin-based drug delivery platform.

He brings over 25 years of drug development experience to the role, most recently as group vice president of BioMarin's neuromuscular franchise.

Prior to this, Dr Campion was both senior vice president of R&D and chief medical officer of Prosensa Holdings, served as global head of clinical R&D at General Electric Healthcare, and was European head of exploratory clinical development at Novartis.

Peter Rosholm, chief executive of Albumedix, said: “I am delighted to welcome Giles Campion to Albumedix.

“His depth of experience across a broad range of therapeutic indications, drug development track record and expertise in the filings of specialised pharmaceuticals, will be invaluable to us as we move our pre-clinical drug candidates towards the clinic.

“The appointment marks the latest step in our growth strategy as we work to advance breakthroughs in the use of albumin-based technologies in the development of life-changing therapeutics.”

16th January 2017

From: Research

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Langland

Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...

Latest intelligence

How ‘Greenwashing’ accusations could delay the very changes its supporters demand
Are shouts of companies ‘greenwashing’ to provide a façade of environmental and ethical respectability causing more harm than good? Or should we call out practices that we believe are papering...
What does the future hold for clinical trial recruitment?
The past couple of years have raised several aspects of healthcare in the public’s consciousness – and one of the leading ones has been the role of clinical trials in...
When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...